Literature DB >> 9533444

C1-esterase inhibitor blocks T lymphocyte proliferation and cytotoxic T lymphocyte generation in vitro.

M H Nissen1, S Bregenholt, J A Nording, M H Claesson.   

Abstract

We have previously shown that activated C1s complement and activated T cells cleave beta2-microglobulin (beta2m) in vitro leading to the formation of desLys58 beta2m. This process can specifically be inhibited by C1-esterase inhibitor (C1-inh). Furthermore we showed that exogenously added desLys58 beta2m in nanomolar amounts to a one-way allogenic mixed lymphocyte culture (MLC) increased the endogenous production of IL-2 and the generation of allo-specific cytotoxic T lymphocytes. C1-inh was purified from fresh human plasma and added to human or murine MLC and mitogen-stimulated lymphocyte cultures grown in the presence of complement-inactivated serum. Read-outs were cell proliferation, lymphokine production and development of T cell-mediated cytotoxicity. We found that addition of C1-inh to MLC and mitogen-exposed murine and human lymphocyte cultures inhibited proliferation, the development of allospecific cytotoxic activity, and changed the endogenous production of IL-2, IL-4, IL-10, IL-12 and IFN-gamma. These data clearly demonstrate a regulatory function of C1-inh on T cell-mediated immune functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9533444     DOI: 10.1093/intimm/10.2.167

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

Review 1.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

2.  In vitro activated CD4+ T cells from interferon-gamma (IFN-gamma)-deficient mice induce intestinal inflammation in immunodeficient hosts.

Authors:  S Bregenholt; J Brimnes; M H Nissen; M H Claesson
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 3.  Targeting Neuromyelitis Optica Pathogenesis: Results from Randomized Controlled Trials of Biologics.

Authors:  Laura Cacciaguerra; Paola Tortorella; Maria A Rocca; Massimo Filippi
Journal:  Neurotherapeutics       Date:  2021-04-28       Impact factor: 6.088

4.  Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica.

Authors:  Michael Levy; Maureen A Mealy
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-04-24

5.  Change in the immune function of porcine iliac artery endothelial cells infected with porcine circovirus type 2 and its inhibition on monocyte derived dendritic cells maturation.

Authors:  Ning Yang; Jinzeng Qiao; Shiyu Liu; Zhanming Zou; Linlin Zhu; Xinyu Liu; Shuanghai Zhou; Huanrong Li
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

6.  Heat-Inactivation of Human Serum Destroys C1 Inhibitor, Pro-motes Immune Complex Formation, and Improves Human T Cell Function.

Authors:  Matthias A Fante; Sonja-Maria Decking; Christina Bruss; Stephan Schreml; Peter J Siska; Marina Kreutz; Kathrin Renner
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.